APOL3
Basic information
Region (hg38): 22:36139792-36166177
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the APOL3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 24 | 32 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 2 | |||||
Total | 0 | 0 | 25 | 5 | 6 |
Variants in APOL3
This is a list of pathogenic ClinVar variants found in the APOL3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-36141214-A-G | not specified | Uncertain significance (Nov 20, 2023) | ||
22-36141225-C-T | not specified | Likely benign (Oct 26, 2022) | ||
22-36141280-G-A | not specified | Uncertain significance (Dec 07, 2023) | ||
22-36141397-G-A | not specified | Uncertain significance (Aug 12, 2021) | ||
22-36141418-G-A | not specified | Uncertain significance (Jan 03, 2024) | ||
22-36141431-A-C | not specified | Uncertain significance (Mar 29, 2022) | ||
22-36141489-A-G | not specified | Uncertain significance (Sep 20, 2023) | ||
22-36141522-C-T | not specified | Uncertain significance (Dec 14, 2022) | ||
22-36141537-A-G | not specified | Uncertain significance (Aug 11, 2022) | ||
22-36141592-T-A | not specified | Uncertain significance (Nov 18, 2022) | ||
22-36141597-C-T | not specified | Likely benign (Jan 08, 2024) | ||
22-36141675-G-A | not specified | Uncertain significance (Oct 12, 2022) | ||
22-36141723-G-A | not specified | Uncertain significance (Mar 28, 2023) | ||
22-36141727-C-T | Benign (Apr 09, 2018) | |||
22-36141732-A-G | not specified | Uncertain significance (Jan 06, 2023) | ||
22-36141735-C-T | not specified | Uncertain significance (Jun 18, 2021) | ||
22-36141750-G-A | Benign (Apr 16, 2018) | |||
22-36141764-C-T | Likely benign (Dec 31, 2019) | |||
22-36141795-C-A | not specified | Uncertain significance (Dec 19, 2022) | ||
22-36141889-C-T | not specified | Uncertain significance (Sep 29, 2023) | ||
22-36142005-G-A | Benign (Dec 31, 2019) | |||
22-36142014-G-A | not specified | Uncertain significance (Jan 30, 2024) | ||
22-36142057-C-G | not specified | Uncertain significance (Feb 13, 2024) | ||
22-36145519-T-C | Benign (May 17, 2018) | |||
22-36145569-T-C | not specified | Uncertain significance (Dec 05, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
APOL3 | protein_coding | protein_coding | ENST00000349314 | 3 | 25854 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000436 | 0.434 | 122099 | 436 | 3203 | 125738 | 0.0146 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0414 | 228 | 226 | 1.01 | 0.0000123 | 2569 |
Missense in Polyphen | 56 | 68.556 | 0.81685 | 801 | ||
Synonymous | -0.879 | 101 | 90.4 | 1.12 | 0.00000494 | 857 |
Loss of Function | 0.0582 | 5 | 5.14 | 0.972 | 2.17e-7 | 64 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.231 | 0.229 |
Ashkenazi Jewish | 0.00546 | 0.00547 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000652 | 0.000519 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000261 | 0.000261 |
Other | 0.00750 | 0.00752 |
dbNSFP
Source:
- Function
- FUNCTION: May affect the movement of lipids in the cytoplasm or allow the binding of lipids to organelles.;
Intolerance Scores
- loftool
- 0.851
- rvis_EVS
- 1.18
- rvis_percentile_EVS
- 92.78
Haploinsufficiency Scores
- pHI
- 0.0436
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.410
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0738
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- lipid transport;inflammatory response;lipoprotein metabolic process;positive regulation of I-kappaB kinase/NF-kappaB signaling
- Cellular component
- extracellular region;cytoplasm;membrane
- Molecular function
- lipid transporter activity;lipid binding